Difference between revisions of "CAR T-cell toxicity management"
Jump to navigation
Jump to search
m (→Grading toxicity: fixed file formatting) |
m |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | ''' | + | '''<big>This page is in process of being created.''' For preparatory regimens for CAR T-cell therapy, please go to [[Chimeric antigen receptor T cells (CAR-T)|this page]].</big> |
{{TOC limit|limit=4}} | {{TOC limit|limit=4}} | ||
| Line 15: | Line 15: | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
| − | [[Category:Supportive | + | [[Category:Supportive oncology]] |
| − | |||
Latest revision as of 14:26, 11 October 2023
This page is in process of being created. For preparatory regimens for CAR T-cell therapy, please go to this page.
Grading toxicity
CTCAE
- Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) - Adverse event grading for clinical trials[1]
Evaluation
Management
References
- ↑ Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) - Adverse event grading for clinical trials
- ↑ CTCAE 5x7" small booklet format local backup
- ↑ CTCAE 8.5x11" letter size format local backup